Global Tissue Diagnostics Market Size study, by Product (Consumables, Instruments), Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining), by Application (Breast Cancer, Gastric Cancer, Prostate Cancer, Lymphoma, Non-Small Cell Lung Cancer (NSCLC), Others), by End-User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, Others) and Regional Forecasts 2020-2027
Global Tissue Diagnostics Market is valued approximately USD 3.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2020-2027. Tissue diagnostics is rapidly serving as the gold standards for diagnosis of cancer. Tissue diagnostics is a type of technique used in removal of tissue from the patient’s body, which is then processed, tested and analyzed under the microscope to perceive the diseases, such as cancer. Tissue diagnostics is primarily performed by needle aspiration cytology, core biopsy and open biopsy. The advancements in these techniques and equipment of tissue diagnostics helps in quick and precise determination and evaluation of diseases associated to the tissues. Further, high adoption of automated tissue diagnostics system, increasing incidences of cancer owing to growing aging population, and rise in healthcare expenditure across the globe are the few factors responsible for high CAGR of the market during the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases and 9.5 million cancer deaths were totaled in 2018 worldwide. Also, it is predicted that it would grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. With the rise in prevalence of cancer, the adoption & utility for tissue diagnostics is likely to grow around the world. Moreover, the outbreak of COVID-19 around the world stressed a major concern on the governments of all COVID-19 hit nations. Since, there is an excruciating need to test and screen a large number of patients for possible Sars-Cov-2 infection. As a result, most of the nations are facing a major shortage in the supply for diagnostic kits to test this virus. Therefore, tissue diagnostics virology suppliers are under immense pressure to deliver reliable testing kits, and therefore, there is a surge in demand for tissue diagnostics systems worldwide. However, high degree of consolidation and budget constraints are the factors impeding the growth of market over the forecast period of 2020-2027.
The regional analysis of global Tissue Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing number of patients with COVID-19 infections, along with the ongoing advancements in the field of gene & immunoassay-based products in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising elderly population, rising cases of cancer and improving healthcare infrastructure would create lucrative growth prospects for the tissue diagnostics market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Danaher Corporation
Thermo Fisher Scientific
Abbott Laboratories
Agilent Technologies
Merck KGaA
Sakura Finetek Japan Co., Ltd.
Becton, Dickinson and Company
Bio-Genex Laboratories
Hologic, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
By Technology:
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining
By Application:
Breast Cancer
Gastric Cancer
Prostate Cancer
Lymphoma
Non-Small Cell Lung Cancer (NSCLC)
Others
By End-User:
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Tissue Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Tissue Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing number of patients with COVID-19 infections, along with the ongoing advancements in the field of gene & immunoassay-based products in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising elderly population, rising cases of cancer and improving healthcare infrastructure would create lucrative growth prospects for the tissue diagnostics market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Danaher Corporation
Thermo Fisher Scientific
Abbott Laboratories
Agilent Technologies
Merck KGaA
Sakura Finetek Japan Co., Ltd.
Becton, Dickinson and Company
Bio-Genex Laboratories
Hologic, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
By Technology:
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining
By Application:
Breast Cancer
Gastric Cancer
Prostate Cancer
Lymphoma
Non-Small Cell Lung Cancer (NSCLC)
Others
By End-User:
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Tissue Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Tissue Diagnostics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Tissue Diagnostics Market, by Product, 2018-2027 (USD Billion)
1.2.3. Tissue Diagnostics Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Tissue Diagnostics Market, by Application, 2018-2027 (USD Billion)
1.2.5. Tissue Diagnostics Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL TISSUE DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL TISSUE DIAGNOSTICS MARKET DYNAMICS
3.1. Tissue Diagnostics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL TISSUE DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Tissue Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Tissue Diagnostics Market, Sub Segment Analysis
5.4.1. Consumables
5.4.2. Instruments
CHAPTER 6. GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Tissue Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. In Situ Hybridization (ISH)
6.4.3. Digital Pathology and Workflow Management
6.4.4. Special Staining
CHAPTER 7. GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Tissue Diagnostics Market by Application - Potential Analysis
7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Tissue Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Gastric Cancer
7.4.3. Prostate Cancer
7.4.4. Lymphoma
7.4.5. Non-Small Cell Lung Cancer (NSCLC)
7.4.6. Others
CHAPTER 8. GLOBAL TISSUE DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Tissue Diagnostics Market by End-User - Potential Analysis
8.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
8.4. Tissue Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Research Laboratories
8.4.3. Pharmaceutical Companies
8.4.4. Contract Research Organizations
8.4.5. Others
CHAPTER 9. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Tissue Diagnostics Market, Regional Market Snapshot
9.2. North America Tissue Diagnostics Market
9.2.1. U.S. Tissue Diagnostics Market
9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Tissue Diagnostics Market
9.3. Europe Tissue Diagnostics Market Snapshot
9.3.1. U.K. Tissue Diagnostics Market
9.3.2. Germany Tissue Diagnostics Market
9.3.3. France Tissue Diagnostics Market
9.3.4. Spain Tissue Diagnostics Market
9.3.5. Italy Tissue Diagnostics Market
9.3.6. Rest of Europe Tissue Diagnostics Market
9.4. Asia-Pacific Tissue Diagnostics Market Snapshot
9.4.1. China Tissue Diagnostics Market
9.4.2. India Tissue Diagnostics Market
9.4.3. Japan Tissue Diagnostics Market
9.4.4. Australia Tissue Diagnostics Market
9.4.5. South Korea Tissue Diagnostics Market
9.4.6. Rest of Asia Pacific Tissue Diagnostics Market
9.5. Latin America Tissue Diagnostics Market Snapshot
9.5.1. Brazil Tissue Diagnostics Market
9.5.2. Mexico Tissue Diagnostics Market
9.6. Rest of The World Tissue Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffmann-La Roche AG
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Danaher Corporation
10.2.3. Thermo Fisher Scientific
10.2.4. Abbott Laboratories
10.2.5. Agilent Technologies
10.2.6. Merck KGaA
10.2.7. Sakura Finetek Japan Co.,Ltd.
10.2.8. Becton, Dickinson and Company
10.2.9. Bio-Genex Laboratories
10.2.10. Hologic, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Tissue Diagnostics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Tissue Diagnostics Market, by Product, 2018-2027 (USD Billion)
1.2.3. Tissue Diagnostics Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Tissue Diagnostics Market, by Application, 2018-2027 (USD Billion)
1.2.5. Tissue Diagnostics Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL TISSUE DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL TISSUE DIAGNOSTICS MARKET DYNAMICS
3.1. Tissue Diagnostics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL TISSUE DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Tissue Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Tissue Diagnostics Market, Sub Segment Analysis
5.4.1. Consumables
5.4.2. Instruments
CHAPTER 6. GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Tissue Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. In Situ Hybridization (ISH)
6.4.3. Digital Pathology and Workflow Management
6.4.4. Special Staining
CHAPTER 7. GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Tissue Diagnostics Market by Application - Potential Analysis
7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Tissue Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Gastric Cancer
7.4.3. Prostate Cancer
7.4.4. Lymphoma
7.4.5. Non-Small Cell Lung Cancer (NSCLC)
7.4.6. Others
CHAPTER 8. GLOBAL TISSUE DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Tissue Diagnostics Market by End-User - Potential Analysis
8.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
8.4. Tissue Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Research Laboratories
8.4.3. Pharmaceutical Companies
8.4.4. Contract Research Organizations
8.4.5. Others
CHAPTER 9. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Tissue Diagnostics Market, Regional Market Snapshot
9.2. North America Tissue Diagnostics Market
9.2.1. U.S. Tissue Diagnostics Market
9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Tissue Diagnostics Market
9.3. Europe Tissue Diagnostics Market Snapshot
9.3.1. U.K. Tissue Diagnostics Market
9.3.2. Germany Tissue Diagnostics Market
9.3.3. France Tissue Diagnostics Market
9.3.4. Spain Tissue Diagnostics Market
9.3.5. Italy Tissue Diagnostics Market
9.3.6. Rest of Europe Tissue Diagnostics Market
9.4. Asia-Pacific Tissue Diagnostics Market Snapshot
9.4.1. China Tissue Diagnostics Market
9.4.2. India Tissue Diagnostics Market
9.4.3. Japan Tissue Diagnostics Market
9.4.4. Australia Tissue Diagnostics Market
9.4.5. South Korea Tissue Diagnostics Market
9.4.6. Rest of Asia Pacific Tissue Diagnostics Market
9.5. Latin America Tissue Diagnostics Market Snapshot
9.5.1. Brazil Tissue Diagnostics Market
9.5.2. Mexico Tissue Diagnostics Market
9.6. Rest of The World Tissue Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffmann-La Roche AG
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Danaher Corporation
10.2.3. Thermo Fisher Scientific
10.2.4. Abbott Laboratories
10.2.5. Agilent Technologies
10.2.6. Merck KGaA
10.2.7. Sakura Finetek Japan Co.,Ltd.
10.2.8. Becton, Dickinson and Company
10.2.9. Bio-Genex Laboratories
10.2.10. Hologic, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. GLOBAL TISSUE DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 2. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2017-2027 (USD BILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2017-2027 (USD BILLION)
TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2017-2027 (USD BILLION)
TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 17. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 18. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 21. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 24. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 27. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 30. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 33. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 36. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 39. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 42. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 45. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 48. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 51. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 54. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 55. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 56. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
TABLE 57. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
TABLE 58. YEARS CONSIDERED FOR THE STUDY
TABLE 59. EXCHANGE RATES CONSIDERED
TABLE 1. GLOBAL TISSUE DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 2. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2017-2027 (USD BILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2017-2027 (USD BILLION)
TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2017-2027 (USD BILLION)
TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 17. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 18. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 21. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 24. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 27. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 30. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 33. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 36. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 39. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 42. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 45. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 48. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 51. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 54. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 55. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 56. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
TABLE 57. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
TABLE 58. YEARS CONSIDERED FOR THE STUDY
TABLE 59. EXCHANGE RATES CONSIDERED
LIST OF FIGURES
FIG 1. GLOBAL TISSUE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL TISSUE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL TISSUE DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL TISSUE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL TISSUE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL TISSUE DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL TISSUE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL TISSUE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
F. Hoffmann-La Roche AG
Danaher Corporation
Thermo Fisher Scientific
Abbott Laboratories
Agilent Technologies
Merck KGaA
Sakura Finetek Japan Co., Ltd.
Becton, Dickinson and Company
Bio-Genex Laboratories
Hologic, Inc.
FIG 1. GLOBAL TISSUE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL TISSUE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL TISSUE DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL TISSUE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL TISSUE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL TISSUE DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL TISSUE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL TISSUE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
F. Hoffmann-La Roche AG
Danaher Corporation
Thermo Fisher Scientific
Abbott Laboratories
Agilent Technologies
Merck KGaA
Sakura Finetek Japan Co., Ltd.
Becton, Dickinson and Company
Bio-Genex Laboratories
Hologic, Inc.
